Expression of β-adrenergic receptor kinase subtypes in the pregnant rat myometrium - 10/09/11
Abstract |
OBJECTIVE: This study tested the hypothesis that the increase in uterine tachyphylaxis to β-adrenergic stimulation during pregnancy is associated with increased expression of the β-adrenergic receptor–inactivating protein kinases.
STUDY DESIGN: Messenger ribonucleic acid was isolated from snap-frozen myometrium collected from nonpregnant and pregnant rats ranging from 10 to 22 days of gestation. Autoradiographic analysis of β-adrenergic receptor–inactivating protein kinase messenger ribonucleic acid expression was performed after hybridization with specific complementary deoxyribonucleic acid probes for types 1 and 2 β-adrenergic receptor–inactivating protein kinases. Probe-specific hybridization was normalized for ribosomal ribonucleic acid detected with methylene blue. Protein expression was detected by Western analysis with use of specific polyclonal antibodies.
RESULTS: Myometrial β-adrenergic receptor–inactivating protein kinase type 2 messenger ribonucleic acid and protein levels increased during the course of pregnancy and in postpartum day 1. In contrast, type 1 levels remained unchanged during the same period. Estrogen treatment resulted in a modest 20% decrease in messenger ribonucleic acid levels of both subtypes. This effect was reversed with progesterone treatment.
CONCLUSION: These results suggest that the myometrium undergoes a functional remodeling late in pregnancy to a state promoting myometrial contractions. The increased myometrial expression of type 2 β-adrenergic receptor–inactivating kinase may explain the decreased effectiveness of β2-adrenergic receptor–mediated contraction inhibition at the end of pregnancy and labor. (Am J Obstet Gynecol 1997;176:1077-83.)
Le texte complet de cet article est disponible en PDF.Keywords : β-Adrenergic receptors, rat myometrium, pregnancy
Plan
From the Departments of Obstetrics, Gynecology, and Reproductive Sciences and Cell Biology and Physiology, University of Pittsburgh School of Medicine, and the Magee-Womens Research Institute. |
|
Reprint requests: Julie A. DeLoia, PhD, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, 204 Craft Ave., Pittsburgh, PA 15213. |
|
0002-9378/97 $5.00 + 0 6/1/80659 |
Vol 176 - N° 5
P. 1077-1083 - mai 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?